{"id":"https://openalex.org/W2051996751","doi":"https://doi.org/10.1016/j.jval.2013.03.361","title":"The Impact Of Clostridium Difficile Infection On Medicare Beneficiary Health Care Utilization And Outcomes","display_name":"The Impact Of Clostridium Difficile Infection On Medicare Beneficiary Health Care Utilization And Outcomes","publication_year":2013,"publication_date":"2013-05-01","ids":{"openalex":"https://openalex.org/W2051996751","doi":"https://doi.org/10.1016/j.jval.2013.03.361","mag":"2051996751"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2013.03.361","doi":"https://doi.org/10.1016/j.jval.2013.03.361","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2013.03.361","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.jval.2013.03.361","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089071500","display_name":"Edward M. Drozd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E.M. Drozd","raw_affiliation_strings":["Avalere Health, LLC, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avalere Health, LLC, Washington, DC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043263684","display_name":"Sij Hemal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Hemal","raw_affiliation_strings":["Optimer Pharmaceuticals, Inc., Jersey City, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optimer Pharmaceuticals, Inc., Jersey City, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"S.M. Thomas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S.M. Thomas","raw_affiliation_strings":["Optimer Pharmaceuticals, Inc., Jersey City, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optimer Pharmaceuticals, Inc., Jersey City, NJ, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046146142","display_name":"Shamonda F. Braithwaite","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S.F. Braithwaite","raw_affiliation_strings":["Avalere Health, LLC, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avalere Health, LLC, Washington, DC, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"3","first_page":"A79","last_page":"A79"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clostridium-difficile-infection","display_name":"Clostridium difficile infection","score":0.9980000257492065},{"id":"https://openalex.org/keywords/medicare-beneficiaries","display_name":"Medicare beneficiaries","score":0.9340000152587891},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.7820000052452087},{"id":"https://openalex.org/keywords/hospital-readmission","display_name":"hospital readmission","score":0.8040000200271606},{"id":"https://openalex.org/keywords/patient-mortality","display_name":"patient mortality","score":0.6740000247955322},{"id":"https://openalex.org/keywords/hospitalization-costs","display_name":"hospital costs","score":0.8569999933242798},{"id":"https://openalex.org/keywords/post-discharge-costs","display_name":"post-discharge costs","score":0.8870000243186951},{"id":"https://openalex.org/keywords/disease-burden","display_name":"disease burden","score":0.8299999833106995},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.4790000021457672}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9508916139602661},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.7299121618270874},{"id":"https://openalex.org/C2994496256","wikidata":"https://www.wikidata.org/wiki/Q27031090","display_name":"Clostridium difficile","level":3,"score":0.7076184153556824},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.6322562098503113},{"id":"https://openalex.org/C2780724011","wikidata":"https://www.wikidata.org/wiki/Q1295316","display_name":"Emergency department","level":2,"score":0.5439959764480591},{"id":"https://openalex.org/C2779195980","wikidata":"https://www.wikidata.org/wiki/Q5691206","display_name":"Healthcare Cost and Utilization Project","level":3,"score":0.5372611880302429},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.5358800292015076},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.3571888506412506},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23887097835540771},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2013.03.361","doi":"https://doi.org/10.1016/j.jval.2013.03.361","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2013.03.361","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2013.03.361","doi":"https://doi.org/10.1016/j.jval.2013.03.361","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2013.03.361","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4220941356","https://openalex.org/W2587089184","https://openalex.org/W2898861944","https://openalex.org/W2515633338","https://openalex.org/W2900400020","https://openalex.org/W2041846466","https://openalex.org/W2550389865","https://openalex.org/W1972197960","https://openalex.org/W2890134860","https://openalex.org/W2591594292"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}